CIK 0001326732 · Accelerated filer
Xencor Inc
Sign in to watch- Ticker
- XNCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 201622502
- Phone
- 626-305-5900
- Business address
- 465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,591,617
- in 2 filings
Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-12 | SIMPSON TODD E Director | Grant or award · Stock Option (Right to Buy) | +27,372 | 27,372 | ||
| 2025-06-12 | RANIERI RICHARD J Director | Grant or award 10b5-1 | +13,686 | 22,176 | ||
| 2025-06-12 | RANIERI RICHARD J Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +27,372 | 27,372 | ||
| 2025-05-02 | Valente Nancy EVP, Chief Development Officer | Sale | −4,616 | $11.03 | $51K | 49,169 |
| 2025-04-10 | Cornelissen Bart Jan SR. VICE PRESIDENT & CFO | Sale | −3,750 | $8.06 | $30K | 61,348 |
| 2025-03-13 | SIMPSON TODD E Director | Grant or award · Stock Option (Right to Buy) | +43,337 | 43,337 | ||
| 2025-03-10 | Valente Nancy EVP, Chief Development Officer | Sale | −2,565 | $13.60 | $35K | 53,785 |
| 2025-03-10 | Eckert Celia SVP, GENERAL COUNSEL | Sale | −5,740 | $13.60 | $78K | 63,507 |
| 2025-03-10 | Desjarlais John R SR. VICE PRESIDENT & CSO | Sale | −9,697 | $13.60 | $132K | 236,574 |
| 2025-03-10 | Dahiyat Bassil I PRESIDENT & CEO | Sale | −19,716 | $13.60 | $268K | 465,419 |
| 2025-03-04 | Desjarlais John R SR. VICE PRESIDENT & CSO | Grant or award | +29,851 | 246,271 | ||
| 2025-03-04 | Desjarlais John R SR. VICE PRESIDENT & CSO | Grant or award · Stock Option (Right to Buy) | +89,552 | 89,552 | ||
| 2025-03-04 | Eckert Celia SVP, GENERAL COUNSEL | Grant or award | +21,949 | 69,247 | ||
| 2025-03-04 | Eckert Celia SVP, GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +65,847 | 65,847 | ||
| 2025-03-04 | Dahiyat Bassil I PRESIDENT & CEO | Grant or award | +109,745 | 485,135 | ||
| 2025-03-04 | Dahiyat Bassil I PRESIDENT & CEO | Grant or award · Stock Option (Right to Buy) | +329,236 | 329,236 | ||
| 2025-03-04 | Cornelissen Bart Jan SR. VICE PRESIDENT & CFO | Grant or award | +21,949 | 65,098 | ||
| 2025-03-04 | Cornelissen Bart Jan SR. VICE PRESIDENT & CFO | Grant or award · Stock Option (Right to Buy) | +65,847 | 65,847 | ||
| 2025-02-03 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise | +3,542 | $15.69 | $56K | 216,420 |
| 2025-02-03 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise · Stock Option (Right to Buy) | −3,542 | 0 |
Page 5 of 11 · 211 trades